Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-25 @ 9:24 PM
NCT ID:
NCT00615056
Group ID:
EG000
Title:
Axitinib + FOLFIRI
Description:
Axitinib (AG-013736) tablet starting dose 5 milligram (mg) orally twice daily (BID) along with combination chemotherapy of irinotecan, 5- flurouracil (5-FU) and leucovorin (LV) (FOLFIRI) regimen consisting of irinotecan 180 mg per square meter (mg/m\^2) 90 minutes intravenous (IV) infusion, concurrently with LV 400 mg/m\^2 (or levo-leucovarin \[l-LV\] 200 mg /m\^2) 2 hours (hrs) IV infusion followed immediately by 5-FU 400 mg/m\^2 IV bolus injection and a subsequent 5-FU 2400 mg/m\^2 46-48 hrs IV infusion on Day 1 of each 2 week cycle.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
17
Serious Number At Risk:
46
Other Number Affected:
45
Other Number At Risk:
46
Study:
NCT00615056
Results Section:
NCT00615056
Adverse Events Module:
NCT00615056